Phase 1/2 Lyme Vaccine Study

This study has been completed.
Sponsor:
Collaborator:
Baxter Innovations GmbH
Information provided by (Responsible Party):
Baxalta US Inc.
ClinicalTrials.gov Identifier:
NCT01504347
First received: December 22, 2011
Last updated: June 26, 2015
Last verified: March 2014